GGrantIndex
Sort

48,018 grants matching immunotherapy

Novel Cord Blood-Derived Cellular Therapies

$2,508,224
Elizabeth J Shpall · University Of Tx Md Anderson Can Ctr · P01 · FY2019 · CA

The Biology of HIV Infections

$2,505,731
Malcolm Martin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

IMPROVING CORD BLOOD TRANSPLANTATION

$2,501,399
Elizabeth J Shpall · University Of Tx Md Anderson Can Ctr · P01 · FY2011 · CA

DF/HCC Renal Cancer SPORE

$2,500,001
Beth Israel Deaconess Medical Center · P50 · FY2003 · CA

SPORE in Gastrointestinal Cancers

$2,500,000
Alison P Klein · Johns Hopkins University · P50 · FY2018 · CA

SPORE in Cervical Cancer

$2,500,000
Johns Hopkins University · P50 · FY2003 · CA

Yale SPORE in Skin Cancer

$2,500,000
Marcus W Bosenberg · Yale University · P50 · FY2018 · CA

Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer

$2,500,000
George J Weiner · University Of Iowa · P50 · FY2018 · CA

SPORE in Breast Cancer

$2,499,932
Charles M Perou · Univ Of North Carolina Chapel Hill · P50 · FY2018 · CA

Targeted Therapies in Melanoma

$2,498,687
Meenhard Herlyn · Wistar Institute · P01 · FY2020 · CA

Role of microbiome in cancer and inflammation

$2,496,470
Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Lymphoma Specialized Program of Research Excellence (SPORE)

$2,496,123
George J Weiner · University Of Iowa · P50 · FY2007 · CA

T Cell Costimulatory Pathways: Functions and Interactions

$2,495,776
Arlene H Sharpe · Harvard Medical School · P01 · FY2023 · AI

T Cell Costimulatory Pathways: Functions and Interactions

$2,495,776
Arlene H Sharpe · Harvard Medical School · P01 · FY2020 · AI

T Cell Costimulatory Pathways: Functions and Interactions

$2,495,776
Arlene H Sharpe · Harvard Medical School · P01 · FY2022 · AI

T Cell Costimulatory Pathways: Functions and Interactions

$2,495,776
Arlene H Sharpe · Harvard Medical School · P01 · FY2021 · AI

Growth Factor Imaging and Photoimmunotherapy

$2,495,095
Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting

$2,494,906
Song Yao · Roswell Park Cancer Institute Corp · UH3 · FY2023 · CA

Experimental Therapy for Brain Tumors

$2,494,255
David M. Ashley · Duke University · P01 · FY2022 · CA

Center for Cell-based Therapy - Cures

$2,493,170
Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

IMPROVING CORD BLOOD TRANSPLANTATION

$2,492,597
Elizabeth J Shpall · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA

Fred Hutchinson Cancer Research Center Lung SPORE

$2,491,191
A. McGarry Houghton · Fred Hutchinson Cancer Research Center · P50 · FY2019 · CA

Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response

$2,490,943
Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2020 · CA

Hematopoiesis in Cardiovascular Disease

$2,488,354
Matthias Nahrendorf · Massachusetts General Hospital · P01 · FY2025 · HL

Targeted Therapies in Melanoma

$2,487,446
Meenhard Herlyn · Wistar Institute · P01 · FY2021 · CA